Turning on ILC2s: diet control
Open Access
- 1 April 2021
- journal article
- editorial
- Published by Wiley in Immunology & Cell Biology
- Vol. 99 (4), 344-347
- https://doi.org/10.1111/imcb.12429
Abstract
New research by Fali and colleagues shows that peroxisome proliferator-activated receptor gamma is a central metabolic regulator of group 2 innate lymphoid cells, controlling the functional activation of these potent innate immune initiators in lung and adipose tissue.This publication has 18 references indexed in Scilit:
- Role of airway glucose in bacterial infections in patients with chronic obstructive pulmonary diseaseJournal of Allergy and Clinical Immunology, 2018
- Innate lymphoid cells at the interface between obesity and asthmaImmunology, 2017
- PPAR-γ promotes type 2 immune responses in allergy and nematode infectionScience Immunology, 2017
- Critical role of fatty acid metabolism in ILC2-mediated barrier protection during malnutrition and helminth infectionThe Journal of Experimental Medicine, 2016
- Increased airway glucose increases airway bacterial load in hyperglycaemiaScientific Reports, 2016
- Innate lymphoid cells contribute to allergic airway disease exacerbation by obesityJournal of Allergy and Clinical Immunology, 2016
- Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophagesNature Immunology, 2014
- PPARγ and the global map of adipogenesis and beyondTrends in Endocrinology & Metabolism, 2014
- PPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cellsNature, 2012
- Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenaseNature, 1999